About Our Company Breadcrumb Home About Page Sub Nav Our Team Our History Corporate Stewardship NeoUniversity Investors Regulatory Careers Employee Benefits NeoGenomics is a premier cancer diagnostic, pharma services, and information services company serving oncologists, pathologists, pharmaceutical companies, and academic centers in their pursuit of providing better futures for people living with cancer. Our vision brings together uncompromising quality, exceptional service, and innovative solutions. Each member of our team is committed to our mission: Save lives by improving patient CARE through Communication, Accuracy, Reliability, and Efficiency. NeoGenomics Laboratories has been serving patients for over 18 years, developing and delivering laboratory diagnostic and clinical trial services with a focus on cancer. NeoGenomics is comprised of an international team of physicians, scientists, and laboratory professionals, who work in partnership with cancer care teams to deliver vital oncology answers to transform the lives of patients living with cancer. We believe that precision oncology is a critical component in controlling cancer progression. With our comprehensive menu ranging from traditional to state-of-the-art testing, our clinical diagnostic services support a personalized testing approach, providing tailored and targeted diagnostics to meet your patient’s needs, no matter where they are in their treatment journey. Our pharma services and data services work synchronously together with you – our partners – to solve the most pressing challenges that patients and their care teams face every day. Our informatics experts can help identify and stratify the right patient cohorts to inform market opportunity, optimize clinical trial design, and improve drug development by increasing patient access to commercial and investigational agents and trials. We are dedicated to providing you and your teams with precise diagnostic testing, helping you bring new therapies to market, and identifying the unique hallmarks of each patient’s disease to enable precision oncology care. NeoGenomics meets you where you are through our network of CAP-accredited, CLIA-certified facilities in the U.S., our global laboratories, as well as our network of national, certified mobile phlebotomy providers. OUR EXPERTISE We create unparalleled partnerships with our clients to develop life-changing therapeutics, tests, and processes to support our mission of saving lives through enhanced patient care. Through our expertise, customization, and scalability, NeoGenomics supports clients in cancer-related market segments, including hospital and private pathology laboratories, office-based oncologists, academic institutions, contract research and pharmaceutical development organizations, and more. We are tirelessly pushing the boundaries and improving our capabilities to provide our partners with the most technologically advanced testing available, integrating the latest clinical evidence and guidelines to advance the care of all patients. Main navigation Diagnostic Services Pharma Services Data Services Inivata Patients Test Menu CONTACT US 9490 NeoGenomics Way Fort Myers, FL 33912 T: 239.768.0600 F: 239.690.4237 Glassdoor Icon Linkedin Icon Twitter Icon YouTube Icon MORE FROM NEO InVisionFirst®-Lung Lung Cancer Awareness Biomarker Assist™ KRAS SGT PIK3CA Mutation CDx Thyroid Testing Program NTRK NEONEWS SIGN UP Receive weekly updates on NeoGenomics tests, research, events, and publications. First Name last Name Email One Lab. Vital Answers. Transforming Care for Cancer Patients. Footer Utility Client Services About Billing Contact Careers NeoLink Login Copyright © 2021 NeoGenomics Laboratories. All rights Reserved. Privacy. Terms. Licensing. Do not sell my personal information. Contact Form Toggle Patients Patients - 4760 Test Menu Header Utility Client Services Client Services - 5025 About About - 4206 Billing Billing - 3379 Careers Contact NeoLINK Login We use cookies on this site to enhance your user experience By clicking the Accept button, you agree to us doing so. More info OK, I agree